SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-190281
Filing Date
2014-05-08
Accepted
2014-05-08 17:12:28
Documents
13
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d717969d10q.htm 10-Q 651914
2 EX-10.2 d717969dex102.htm EX-10.2 34916
3 EX-10.3 d717969dex103.htm EX-10.3 18732
4 EX-10.4 d717969dex104.htm EX-10.4 21347
5 EX-31.1 d717969dex311.htm EX-31.1 6227
6 EX-31.2 d717969dex312.htm EX-31.2 6248
7 EX-32.1 d717969dex321.htm EX-32.1 4523
  Complete submission text file 0001193125-14-190281.txt   4035214

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT acrx-20140331.xml EX-101.INS 537271
9 XBRL TAXONOMY EXTENSION SCHEMA acrx-20140331.xsd EX-101.SCH 40614
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE acrx-20140331_cal.xml EX-101.CAL 43228
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE acrx-20140331_def.xml EX-101.DEF 133648
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE acrx-20140331_lab.xml EX-101.LAB 314660
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE acrx-20140331_pre.xml EX-101.PRE 212239
Mailing Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063
Business Address 351 GALVESTON DRIVE REDWOOD CITY CA 94063 650-216-3500
ACELRX PHARMACEUTICALS INC (Filer) CIK: 0001427925 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35068 | Film No.: 14825957
SIC: 2834 Pharmaceutical Preparations